(Q48162316)

9 February 2018

title

Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors. (English)

1 reference

9 February 2018

0 references

1 reference

V Raghavendra

1

1 reference

9 February 2018

S K Kulkarni

series ordinal

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

9 February 2018

volume

834

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

178-181

1 reference

9 February 2018

Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Melatonin effects on behavior: possible mediation by the central GABAergic system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Influence of different benzodiazepines on the experimental morphine abstinence syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Pertussis toxin inhibits morphine analgesia and prevents opiate dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Opiate-dependent modulation of adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

PK 11195 blockade of benzodiazepine-induced inhibition of forskolin-stimulated adenylate cyclase activity in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Cellular mechanisms of melatonin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901520-6

10.1016/S0006-8993(99)01520-6

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10407111

1 reference

9 February 2018